In the United States District Court for the Northern District of West Virginia, Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc. have filed a lawsuit against Mylan Pharmaceuticals Inc. The case ID is 1:24-cv-00036-TSK and it was filed on April 5, 2024. The plaintiffs allege patent infringement by the defendant.
The plaintiffs, represented by their legal counsel, are accusing Mylan Pharmaceuticals of infringing on United States Patent No. 11,834,521. This patent relates to the defendant's filing of an Abbreviated New Drug Application (ANDA) seeking U.S. Food and Drug Administration (FDA) approval to market its generic plecanatide oral tablets, 3 mg.
The defendant is accused of developing, manufacturing, marketing, importing, and selling pharmaceutical products that infringe on the plaintiff's patent rights. The plaintiffs claim that Mylan Pharmaceuticals' actions have caused significant financial damages.
The plaintiffs are seeking judgment against Mylan Pharmaceuticals for patent infringement and are asking for damages to be awarded in accordance with the harm they have suffered due to the alleged infringement.
